Fruit fly study identifies potential therapeutic target for form of ALS, FTD
UF neuroscientists collaborate on international study revealing a potential therapeutic target for ALS, FTD linked to TDP-43.
Posts tagged as
ALS
FDA approves new ALS drug tested in clinical trial at UF
AMX0035 was tested at UF, Mass General and partnering sites and then approved by the FDA to treat ALS.
MBI Rising Stars: Ariel Walker
Ariel Walker is the latest MBI Rising Star, a video series highlighting up-and-coming neuroscience researchers at UF.
Researchers report experimental drug may prolong survival in ALS patients
Trial drug combination shows potential to prolong survival of ALS patients by more than six months.
New trial drug combination shows promise for slowing progression of ALS
UF was the No. 2 enroller of patients for multisite ALS trial.
Study shows diabetes drug improves symptoms in subtype of ALS in mice
Research led by Drs. Laura Ranum and Tao Zu is encouraging for future treatments for a type of ALS and several other neurological diseases.
Forward motion
One family raised the bar for excellence at UF’s movement disorders program. Learn more in the latest edition of Florida Physician.
New preclinical study shows antibody therapy could offer treatment path for genetic form of ALS
Novel type of immunotherapy used in mouse-model study shows promise for ALS treatment.
Media coverage of Fixel Institute announcement
See media highlights stemming from Jan. 18's Norman Fixel Institute for Neurological Diseases at UF Health gift announcement.
UF and UF Health announce $20 million gift from Lauren and Lee Fixel Foundation
Funds will help launch institute at UF Health for Parkinson’s and other neurodegenerative diseases.
